Cabozantinib for Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cabozantinib for Renal Cell Carcinoma: Current and Future Paradigms
Curr Treat Options Oncol 2017 Mar 01;18(3)18, A Abdelaziz, U VaishampayanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.